Brief: Ryvu Theraputics Q2 Net Loss At 30.4 Mln Zlotys
Sept 11 (Reuters) - Ryvu Theraputics SA RVU.WA :
* SAID ON WEDNESDAY Q2 NET LOSS 30.4 MLN ZLOTYS
* Q2 REVENUE 15.7 MLN ZLOTYS
* Q2 OPERATING LOSS 32.8 MLN ZLOTYS
Source text for Workspace: urn:newsml:reuters.com:*:nEM34KKQba
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project